FDA
-
-
-
-
-
-
-
Trillium Therapeutics Announces Corporate Restructuring and Provides CD47 Program Update
-
-
-
-
-
-
-
Trillium Therapeutics Completes Amendment to SIRPaFc License Agreement
-
-
-
-
-
-
-
Trillium Therapeutics (TRIL) Announces TTI-622 Preclinical Data at 2018 AACR Annual Meeting
-
-
-
-
-
-
-
Trillium Therapeutics Reports Annual 2017 Financial and Operating Results
-
-
-
322,241 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

